CHICAGO — Two bone turnover markers were significantly lower at 3 months and 1 year in postmenopausal women who received estetrol (E4) compared with patients who received placebo, according to a study ...
Researchers analysed data of a subcohort of patients from a prospective observational study to identify factors associated with BMD and the risk for osteoporosis. They included 110 patients with SLE ...
A new consensus paper, published by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), the International Osteoporosis ...
Differences in bone quality between nonarthritic and arthritic ankles may illuminate future intervention strategies for ankle ...
Urinary measurements of N-telopeptide (Ntx) and serum bone alkaline phosphatase (BAP) were obtained in 1,824 bisphosphonate-treated patients—1,462 with zoledronic acid (breast, 490; prostate, 411; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback